JAPAN does not forgive generic strategy.
We help global MedTech, Diagnostics & Advanced Therapeutics companies enter, build and grow in Japan.
Leadership • Market Entry • Clinical Access & Adoption
From first Japan hire to clinical adoption and commercial scale.
BUILT FOR GLOBAL LIFE SCIENCES TEAMS ENTERING OR SCALING JAPAN
We work directly with founders, CEOs, regional leaders and Japan P&L owners when execution depends on getting the market, people and clinical ecosystem right at the same time.
JAPAN EXECUTION, BUILT AROUND THREE CRITICAL CAPABILITIES
01 — LEADERSHIP & TALENT
Build the leadership and specialist teams required to execute in Japan.
Country Management • Commercial • Medical Affairs • Market Access • Regulatory • Clinical • Quality
02 — MARKET ENTRY & GROWTH
Turn global strategy into a Japan operating model that can actually execute.
Market Intelligence • Direct vs Distributor • Organization Design • Launch Readiness • Commercial Strategy
03 — CLINICAL ACCESS & ADOPTION
Build the clinical ecosystem required for innovative technologies to gain traction.
KOL & Investigator Mapping • Evidence Strategy • Clinical Networks • Market Access • Adoption Strategy
JAPAN STRATEGY FAILS AT THE HANDOFF TO EXECUTION.
Strong technology and regulatory approval are not enough.
Japan expansion stalls when leadership, clinical adoption, market access and commercial execution are designed independently.
The warning signs usually appear early:
Leadership without local authority.
Regulatory progress without clinical pull.
Distribution without market ownership.
Launch plans without the capabilities to execute them.
Inoventic helps leadership teams identify those gaps before they become expensive reversals.
CLINICAL DEPTH. COMMERCIAL EXECUTION.
Inoventic was founded by Emilio Campos, D.D.S., combining clinical and scientific training with more than two decades inside Japan's healthcare and life-sciences ecosystem.
We work across the interfaces where Japan expansion most often breaks:
Global ↔ Japan
Science ↔ Commercialization
Strategy ↔ Execution
Companies ↔ Clinical Ecosystems
The objective is simple: reduce execution risk and accelerate growth.
EXPERIENCE ACROSS THE JAPAN LIFE SCIENCES ECOSYSTEM
What Our Partners Are Saying…
"Re-entering Japan after a difficult distributor partnership felt like starting from zero. We had no team and a stalled growth trajectory in our second-largest market. Inoventic didn't just find candidates; they served as our strategic partner, building our entire commercial and operational team from the ground up. They understood our uniquely complex talent needs and delivered the 10 leaders who turned our business around, allowing us to hit our ambitious scale-up targets."
— SVP, Global Medical Aesthetics Company
"We chose Japan as the global launchpad for our game-changing new technology, which came with immense investor pressure and zero room for error. The standard commercial profile wasn't a fit for our sensitive category. Inoventic understood this perfectly and secured the two foundational leaders—our APAC Head of Medical Education and Brand Manager—who were instrumental in our success. Their work directly contributed to a successful clinical launch, positive KOL engagement, and a significant increase in our stock price."
— CEO, US-Based FemTech Innovator
"We were at a critical inflection point, facing immense investor pressure to transform our consumer genomics company into a regional, AI-driven data platform for a potential IPO. This required a complete overhaul of our leadership and culture. Inoventic was the strategic partner who architected our new executive dream team. They brought us the A-list leaders—our new CMO, CTO, CSO, and Heads of Comms and PR from companies like Google and Mercari—who laid the foundation to transform our business model and position us as the undisputed leader in our market."
— Board Member, APAC-based Genomics AI Company
HOW WE ENGAGE
EXECUTION SPRINT
A focused engagement around one defined Japan challenge.
Typical mandates: market-entry diagnostic, leadership build, KOL/clinical ecosystem mapping, distributor assessment, launch readiness.
EXECUTIVE SEARCH
Leadership and specialist acquisition for critical Japan roles.
Typical mandates: Country Manager, Commercial, Medical Affairs, Market Access, Regulatory, Clinical and Quality.
FRACTIONAL JAPAN PARTNER
Ongoing senior-level support for global leadership teams building or scaling Japan.
Best for: companies without the need—or readiness—for a full local infrastructure.
